Clinical trial
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
NCT02634177 is registered in ClinicalTrials.gov with Genomind, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
- Lead sponsor
- Genomind, LLC
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- July 25, 2017
- Enrollment
- 305 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.